antithrombin

(redirected from Antithrombins)
Also found in: Dictionary, Encyclopedia, Wikipedia.

antithrombin

 [an″te-throm´bin]
any naturally occurring or therapeutically administered substance that neutralizes the action of thrombin and thus limits or restricts blood coagulation.
antithrombin I fibrin, referring to the capacity of fibrin to adsorb thrombin and thus neutralize it.
antithrombin III a naturally occurring inhibitor of blood coagulation; it is an α2-globulin member of the serpin group, synthesized in the liver and found in the plasma and various extravascular sites. It inactivates thrombin as well as certain coagulation factors and kallikrein. Inherited deficiency of the protein, an autosomal dominant disorder, is associated with recurrent deep vein thrombosis and pulmonary emboli. Complications from the disorder are prevented and, in conjunction with heparin, treated with a preparation of antithrombin III from pooled human plasma, administered intravenously.

an·ti·throm·bin

(an'tē-throm'bin),
Any substance that inhibits or prevents the effects of thrombin in such a manner that blood does not coagulate. A deficiency of antithrombin results in impaired inhibition of coagulation factors IIa, IXa, and Xa in plasma, causing recurrent thrombosis.

antithrombin

/an·ti·throm·bin/ (-throm´bin) any naturally occurring or therapeutically administered substance that neutralizes the action of thrombin and thus limits or restricts blood coagulation.
antithrombin I  fibrin, referring to its capacity to adsorb thrombin and thus neutralize it.
antithrombin III  a plasma α of the serpin family that inactivates thrombin and also inhibits certain coagulation factors and kallikrein. Inherited deficiency is associated with recurrent deep vein thrombosis and pulmonary emboli; the complications are prevented and treated with a preparation of antithrombin III from pooled human plasma.

antithrombin

[-throm′bin]
a plasma serine protease inhibitor that neutralizes thrombin. Antithrombin is a major coagulation control protein.

antithrombin

A plasma protein that diminishes the activity of THROMBIN, or the amount of thrombin produced during or following coagulation of the blood.

Antithrombin

Any substance that counters the effect of thrombin, an enzyme that converts fibrinogen into fibrin, leading to blood coagulation.

antithrombin

any naturally occurring or therapeutically administered substance that neutralizes the action of thrombin and thus limits or restricts blood coagulation.

antithrombin III (AT III)
an alpha2-globulin synthesized in the liver which is a natural inhibitor of clotting.
References in periodicals archive ?
Table 22: Critical Care Market, Global, Antithrombin Cost of Therapy ($), 2010-2017 33
Table 23: Critical Care Market, Global, Antithrombin, Treatment Usage Pattern ('000), 2002-2010 34
Table 24: Critical Care Market, Global, Antithrombin, Treatment Usage Pattern ('000), 2010-2017 34
Figure 13: Critical Care Market, Global, Antithrombin, Revenue ($'000), 2002-2017 29
Figure 14: Critical Care Market, Global Antithrombin Market Breakup (%), 2010 30
Figure 15: Critical Care Market, Global, Antithrombin, Revenue Segmentation ($m), 2002-2017 31
Table 20: Critical Healthcare Market, Global, Antithrombin Revenue Segmentation ($'000), 2010-2017 32
Table 21: Critical Healthcare Market, Global, Antithrombin Cost of Therapy ($), 2002-2010 33
Table 22: Critical Healthcare Market, Global, Antithrombin Cost of Therapy ($), 2010-2017 33
Table 23: Critical Healthcare Market, Global, Antithrombin, Treatment Usage Pattern ('000), 2002-2010 34
Table 24: Critical Healthcare Market, Global, Antithrombin, Treatment Usage Pattern ('000), 2010-2017 34
Figure 13: Critical Healthcare Market, Global, Antithrombin, Revenue ($'000), 2002-2017 29